Skip to content

Vicryl Rapide

by Johnson & Johnson International 88 variants

Ref V2150HModel Vicryl Rapide

Active European Union

CE MDR

Valid until

19 Dec 2027

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier BSI Group The Netherlands B.V.

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR NumberMDR 730044 Date10 Sep 2026IssuedStatusActive expires 19 Dec 2027

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • MDR 730044 Active Supplemented

    Technical documentation EU MDR

    Certifier
    BSI Group The Netherlands B.V. 2797
    Issued
    10 Sep 2026
    Expires
    19 Dec 2027
    Reason
    Change approved

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
VICRYL RAPIDE (Polyglactin 910) Synthetic Absorbable Suture
Model / Reference
Vicryl Rapide, V2150H
Primary DI / UDI-DI
10705031106086
Basic UDI-DI
0705031a012094L
EMDN Code
H010101020201, H010101020202
Device Class
Class III
EU market of registration
Belgium

Manufacturer details

EUDAMED SRN
BE-MF-000008018

Other devices from Johnson & Johnson International

See all devices from Johnson & Johnson International →

Properties

  • Sterile
  • Implantable

Other properties (11)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No